rofecoxib has been researched along with Invasiveness, Neoplasm in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previously, we reported that celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, prevented lung metastases but did not affect tumor growth in a model of Ewing sarcoma." | 7.78 | Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. ( Barlow, M; Edelman, M; Glick, RD; Soffer, SZ; Steinberg, BM, 2012) |
| "Previously, we reported that celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, prevented lung metastases but did not affect tumor growth in a model of Ewing sarcoma." | 3.78 | Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. ( Barlow, M; Edelman, M; Glick, RD; Soffer, SZ; Steinberg, BM, 2012) |
| "PANC-1 and MIAPaCa-2 pancreatic cancer cells were treated with PGE(2) or rofecoxib, a selective COX-2 inhibitor." | 1.32 | Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. ( Ashley, SW; Benoit, E; Clancy, TE; Duxbury, M; Ito, H; Whang, EE; Zinner, MJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlow, M | 1 |
| Edelman, M | 1 |
| Glick, RD | 1 |
| Steinberg, BM | 1 |
| Soffer, SZ | 1 |
| Ito, H | 2 |
| Duxbury, M | 2 |
| Benoit, E | 2 |
| Farivar, RS | 1 |
| Gardner-Thorpe, J | 1 |
| Zinner, MJ | 2 |
| Ashley, SW | 2 |
| Whang, EE | 2 |
| Peluffo, GD | 1 |
| Stillitani, I | 1 |
| RodrÃguez, VA | 1 |
| Diament, MJ | 1 |
| Klein, SM | 1 |
| Clancy, TE | 1 |
4 other studies available for rofecoxib and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma.
Topics: Basement Membrane; Bone Neoplasms; Celecoxib; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Cyc | 2012 |
Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Count; Cell Line, Tumor; Cells, Cultured; Cyc | 2004 |
Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cell Survival; Chem | 2004 |
Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.
Topics: Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Dinoprostone; Enzyme Induction; Extracellular Sig | 2004 |